These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6411812)

  • 21. Analysis of the immune response induced by a single xenoantigen in vivo.
    Sireci G; Dieli F; Barera A; Di Sano C; Bonanno CT; Salerno A
    Immunol Lett; 2005 May; 98(2):245-52. PubMed ID: 15860224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
    Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
    Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy.
    Montgomery B; Lala PK
    J Immunol; 1983 Nov; 131(5):2348-55. PubMed ID: 6415163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of an immune response gene effect by point mutation in the antigen sequence.
    Lechler RI; Bal V; Ikeda H; Trowsdale J; Rothberd JB; Lamb JB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):618-20. PubMed ID: 2495624
    [No Abstract]   [Full Text] [Related]  

  • 27. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
    Shaw S; Ziegler A; DeMars R
    Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
    Batten P; Heaton T; Fuller-Espie S; Lechler RI
    J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
    Stumptner P; Benaroch P
    EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
    Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules.
    Pajot A; Pancré V; Fazilleau N; Michel ML; Angyalosi G; Ojcius DM; Auriault C; Lemonnier FA; Lone YC
    Int Immunol; 2004 Sep; 16(9):1275-82. PubMed ID: 15249541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous peptides contribute to the ligand recognized by anti-DR1 human alloreactive T cells.
    Lombardi G; Sidhu S; Lamb JR; Batchelor JR; Lechler RI
    Transplant Proc; 1989 Feb; 21(1 Pt 1):142-4. PubMed ID: 2495597
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA loss variants of a B27+ lymphoblastoid cell line: genetic and cellular characterization.
    Nicklas JA; Miyachi Y; Taurog JD; Wee SL; Chen LK; Grumet FC; Bach FH
    Hum Immunol; 1984 Sep; 11(1):19-30. PubMed ID: 6090351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens.
    Walker LE; Hewick R; Hunkapiller MW; Hood LE; Dreyer WJ; Reisfeld RA
    Biochemistry; 1983 Jan; 22(1):185-8. PubMed ID: 6600932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical analysis of class II molecules expressed by a human B cell line with the unusual class II genotype, DR5+, MB1+, (MB3-), MT2+.
    Karr RW; Sachs JA; Festenstein H
    Tissue Antigens; 1985 Mar; 25(3):121-9. PubMed ID: 3890265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.